In a clinical trial of two treatments, one goal of the experimenter is to design an experiment such that the number of patients assigned to the inferior treatment is minimized. A Bayesian formulation for this problem is studied. Treatment outcomes are assumed to be independent and normally distributed, with conjugate priors. The analysis is conducted in a large sample limit where sampling costs are scaled to zero. First we show there is little harm restricting attention to procedures that stop according to Kiefer and Sacks stopping rule. There are procedures in this class with risks that exceed the minimum Bayes risk by the cost of a fixed number of observations. Using this we then develop procedures with bounded deficiency. A Monte Carlo s...
We solve a Bayesian decision-theoretic model of a sequential experiment in which the real-valued pri...
Sequential monitoring is a well-known methodology for the design and analysis of clinical trials. Dr...
Medical research has evolved conventions for choosing sample size in randomized clinical trials that...
In a clinical trial of two treatments, one goal of the experimenter is to design an experiment such ...
In sequential experiments the sample size is not planned in advance. Data are progressively collecte...
[[abstract]]In the sequential analysis of data, both Bayesian and frequentist methods often make use...
In this paper we consider a method for monitoring a clinical trial whose patients are sequentially e...
In the conduct of sequential clinical trials, primary statistical issues include design, monitoring ...
Suppose two treatments with binary responses are available for patients with some disease. Sequentia...
Key word and phrases. Decision theory, two-armed bandit problems, sequential treatment allocation, c...
In sequential testing an observer must choose when to observe additional data points and when to sto...
Consider the problem of sequentially testing a null hypothesis vs an alternative hypothesis when the...
Suppose two treatments with binary responses are available for patients with some disease and that e...
[[abstract]]In clinical trials, the use of sequential stopping rules or stopping boundaries has been...
Unplanned optional stopping rules have been criticized for inflating Type I error rates under the nu...
We solve a Bayesian decision-theoretic model of a sequential experiment in which the real-valued pri...
Sequential monitoring is a well-known methodology for the design and analysis of clinical trials. Dr...
Medical research has evolved conventions for choosing sample size in randomized clinical trials that...
In a clinical trial of two treatments, one goal of the experimenter is to design an experiment such ...
In sequential experiments the sample size is not planned in advance. Data are progressively collecte...
[[abstract]]In the sequential analysis of data, both Bayesian and frequentist methods often make use...
In this paper we consider a method for monitoring a clinical trial whose patients are sequentially e...
In the conduct of sequential clinical trials, primary statistical issues include design, monitoring ...
Suppose two treatments with binary responses are available for patients with some disease. Sequentia...
Key word and phrases. Decision theory, two-armed bandit problems, sequential treatment allocation, c...
In sequential testing an observer must choose when to observe additional data points and when to sto...
Consider the problem of sequentially testing a null hypothesis vs an alternative hypothesis when the...
Suppose two treatments with binary responses are available for patients with some disease and that e...
[[abstract]]In clinical trials, the use of sequential stopping rules or stopping boundaries has been...
Unplanned optional stopping rules have been criticized for inflating Type I error rates under the nu...
We solve a Bayesian decision-theoretic model of a sequential experiment in which the real-valued pri...
Sequential monitoring is a well-known methodology for the design and analysis of clinical trials. Dr...
Medical research has evolved conventions for choosing sample size in randomized clinical trials that...